Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-13

Clinical Trial Update: Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus [Phase 4]

View source ↗

Summary

Clinical trial investigating whether adding renin-angiotensin system inhibitors to standard antidiabetic therapy improves glycemic control in adults with Type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nantou Christian Hospital | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED